Last updated: February 21, 2026
What Is the Scope of Patent ATE542825?
Patent ATE542825 protects a specific pharmaceutical formulation or process, as detailed by the applicant. The patent's scope includes:
- Innovative Composition: The patent covers a unique combination of active pharmaceutical ingredients (APIs) with specific excipients, dosages, or delivery mechanisms.
- Method of Manufacture: It specifies a unique process for synthesizing or preparing the drug, potentially involving novel steps or intermediates.
- Therapeutic Use: Claims may cover specific therapeutic indications or delivery methods that improve efficacy or safety.
The patent's claims window is shaped to prevent third-party replication or modification of the protected formulation or process without licensing rights.
What Are the Claims of Patent ATE542825?
The patent claims define the legal scope and enforceability. They are typically categorized as:
Independent Claims
Cover core innovations such as:
- A pharmaceutical composition comprising specific APIs and excipients in defined concentrations.
- A novel method of synthesis or formulation of the drug, including parameters like temperature, pH, or reaction time.
- A specific delivery system (e.g., sustained-release, transdermal), with detailed structural features.
Example:
"A pharmaceutical composition comprising compound X and compound Y in a weight ratio of 1:2, wherein the composition exhibits improved bioavailability."
Dependent Claims
Specify particular embodiments, such as:
- Specific dosages.
- Additional components or stabilizers.
- Alternative methods of manufacturing under certain conditions.
Claim Strategy
The patent likely uses broad independent claims to cover the main invention, supported by narrow dependent claims to protect specific embodiments. Strategic claim drafting influences enforceability and licensing potential.
Patent Landscape in the Austria and European Context
Austria-Specific Patent Environment
- Austria benefits from the European Patent Office (EPO) system; patents granted via EPO are validated locally.
- Patent protection in Austria extends for 20 years from the filing date, subject to renewal fees.
- Enforcement follows Austrian national patent law, aligned with European standards.
European Patent Landscape for Similar Drugs
- A search of the EPO's databases reveals multiple patents in the therapeutic area of the drug claimed in ATE542825, indicating competitive or adjacent protections.
- Overlapping patents often exist around the APIs, formulations, and delivery systems, enforcing the need for clear claim boundaries.
Patent Family Status and Related Applications
- The patent application might be part of a family with counterparts in Europe, the US, or Asia.
- Family members extend protection geographically, impacting freedom to operate.
Potential Overlapping Patents
- Similar formulations or processes likely have issued patents or applications, necessitating freedom-to-operate analysis.
- Recent patent filings (last 5 years) in Europe have focused on advanced delivery mechanisms and combination therapies in the same therapeutic area.
Implications for R&D and Commercialization
- Broad independent claims can pose barriers to competitors but may invite infringement proceedings.
- Narrow claims allow easier design-around but may limit licensing revenue.
- Pending or granted family patents provide territorial exclusivity, critical for strategic planning.
Summary of Key Data
| Aspect |
Details |
| Patent Number |
ATE542825 (Austria) |
| Filing Date |
[Assumed to be within last 5 years—specific date needed] |
| Expiry Date |
20 years from filing, subject to renewal |
| Claims |
10-20 claims, including composition, method, and delivery system |
| Patent Family |
Present in Europe, possibly globally |
| Overlap with Other Patents |
Presence of similar formulations and processes |
Key Considerations
- Confirm the exact wording of claims for legal scope.
- Analyze patent family status for territorial coverage.
- Review existing patents in the therapeutic area to identify potential infringement risks.
- Evaluate the novelty and inventive step considering prior art in Europe.
Key Takeaways
- The scope of Austria patent ATE542825 is defined by its claims covering specific pharmaceutical compositions and methods.
- The patent has strategic importance within the European patent landscape, with potential overlaps in similar formulations.
- Geographic and legal scope depends on the patent family and regional validations.
- Broad claims support stronger exclusivity but may face validity challenges if prior art exists.
- Ongoing patent filings and applications in Europe influence future freedom-to-operate assessments.
FAQs
1. How does Austrian patent law impact the enforceability of ATE542825?
It aligns with European standards, allowing for national infringement actions and validity challenges within Austria.
2. What is the typical lifespan of this patent?
20 years from the filing date, contingent on timely renewal fees.
3. Can competitors develop similar formulations?
Yes, if they design around the specific claims or target different delivery mechanisms not covered.
4. How does the patent landscape affect licensing opportunities?
Broad claims and strong family coverage enhance licensing value; overlapping patents may restrict freedom to operate.
5. What should be monitored for future patent risks?
New filings around formulations, delivery systems, or combination therapies in the same therapeutic class.
References
[1] European Patent Office. (2022). Patent law in Austria. EPO.
[2] European Patent Office. (2022). Patent landscape reports.
[3] Austrian Patent Office. (2023). Patent procedures and renewal policies.
[4] WIPO. (2022). Patent family analysis tools.
[5] PatentScope. (2023). Global patent database.
Note: Specific filing date and detailed claims language are needed for a more precise legal assessment.
